R Nicolás

546 total citations
19 papers, 408 citations indexed

About

R Nicolás is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, R Nicolás has authored 19 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in R Nicolás's work include Renal Diseases and Glomerulopathies (4 papers), Cell Adhesion Molecules Research (3 papers) and Lysosomal Storage Disorders Research (2 papers). R Nicolás is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Cell Adhesion Molecules Research (3 papers) and Lysosomal Storage Disorders Research (2 papers). R Nicolás collaborates with scholars based in Spain, France and Denmark. R Nicolás's co-authors include Jesús Egido, Jordi Yagüe, Xusto Fernández, Manuel Hermida‐Prieto, Francisco Marı́n, Antonio García‐Honrubia, Gonzalo de la Morena, Lorenzo Monserrat, Eduardo Payá and Juan R. Gimeno and has published in prestigious journals such as The Journal of Immunology, Journal of the American College of Cardiology and European Journal of Pharmacology.

In The Last Decade

R Nicolás

18 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Nicolás Spain 8 190 144 87 72 69 19 408
John W. Carpenter United States 12 126 0.7× 101 0.7× 298 3.4× 34 0.5× 84 1.2× 23 678
Julie Dumont France 13 174 0.9× 247 1.7× 352 4.0× 22 0.3× 22 0.3× 20 800
Shigeki Fujisawa Japan 13 120 0.6× 21 0.1× 134 1.5× 55 0.8× 20 0.3× 26 653
Krithika Sundaram United States 12 112 0.6× 38 0.3× 229 2.6× 12 0.2× 12 0.2× 24 461
Violetta D. Dadufalza United States 12 73 0.4× 82 0.6× 165 1.9× 21 0.3× 16 0.2× 18 611
Marvin B. Goldlust United States 11 68 0.4× 23 0.2× 70 0.8× 33 0.5× 17 0.2× 22 322
David W. Crabb United States 13 93 0.5× 193 1.3× 341 3.9× 26 0.4× 10 0.1× 18 719
Banjun Ruan China 7 167 0.9× 80 0.6× 143 1.6× 72 1.0× 25 0.4× 12 333
Rose M. Fields United States 11 112 0.6× 90 0.6× 231 2.7× 13 0.2× 71 1.0× 15 555
K A Chandrabose United States 8 67 0.4× 30 0.2× 135 1.6× 7 0.1× 62 0.9× 11 418

Countries citing papers authored by R Nicolás

Since Specialization
Citations

This map shows the geographic impact of R Nicolás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Nicolás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Nicolás more than expected).

Fields of papers citing papers by R Nicolás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Nicolás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Nicolás. The network helps show where R Nicolás may publish in the future.

Co-authorship network of co-authors of R Nicolás

This figure shows the co-authorship network connecting the top 25 collaborators of R Nicolás. A scholar is included among the top collaborators of R Nicolás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Nicolás. R Nicolás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gallego‐Merlo, J., et al.. (2016). Nine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundación Jiménez Díaz. Molecular Genetics and Metabolism Reports. 9. 79–85. 6 indexed citations
2.
Izquierdo, María C., et al.. (2008). Gliotoxin Inhibits Neointimal Hyperplasia after Vascular Injury in Rats. Journal of Vascular Research. 46(4). 278–289. 7 indexed citations
3.
Monserrat, Lorenzo, Juan R. Gimeno, Francisco Marı́n, et al.. (2007). Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 50(25). 2399–2403. 211 indexed citations
4.
González-Cabrero, J, et al.. (2006). The Proteome of Endothelial Cells. Humana Press eBooks. 357. 181–198. 13 indexed citations
5.
Nicolás, R, et al.. (2006). Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells. European Journal of Pharmacology. 548(1-3). 53–63. 25 indexed citations
6.
Gutiérrez, Cristina, et al.. (2005). Ursolic acid inhibits neointima formation in the rat carotid artery injury model. Atherosclerosis. 184(1). 53–62. 23 indexed citations
7.
Bustos, Carmen, Eva González‐Roca, S. Gonzalez-Cuadrado, et al.. (1996). Urinary excretion of platelet-activating factor in human and experimental nephrosis. Nephrology Dialysis Transplantation. 11(2). 282–286. 9 indexed citations
8.
González, Eva, C. Cruz, R Nicolás, Jesús Egido, & Gabriel Herrero‐Beaumont. (1994). Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Inflammation Research. 41(3-4). 171–178. 65 indexed citations
9.
González-Cabrero, J, R Nicolás, Alberto Ortíz, et al.. (1992). Presence of circulating antibodies against brush border antigens (FxlA) in a patient with membranous nephropathy and bilateral pyeloureteral stenosis. Comparison with idiopathic membranous nephropathy. Nephrology Dialysis Transplantation. 7(4). 293–299. 2 indexed citations
10.
Nicolás, R, et al.. (1991). Kinetics and Regulation of NK Activity by Interleukin‐2 and Interferon in Acute Toxoplasmosis. Scandinavian Journal of Immunology. 34(5). 673–677. 8 indexed citations
11.
González-Cabrero, J, R Nicolás, L Hernando, & J. Egido. (1991). Expression and synthesis of cross-reactive idiotypic antibodies by peripheral blood lymphocytes and their suppression by anti-idiotypes in patients with IgA nephropathy. The Journal of Immunology. 147(12). 4162–4166. 4 indexed citations
13.
Nicolás, R, et al.. (1991). [Effect of erythromycin and phosphomycin on the ingestion and destruction capacity of the human polymorphonuclear leukocyte].. PubMed. 7(7). 374–6. 2 indexed citations
14.
Nicolás, R, et al.. (1990). [Effect of treatment with clindamycin, erythromycin, rifamycin or gentamicin on the ingestion capacity of peritoneal macrophages in mice].. PubMed. 38(1). 13–8. 1 indexed citations
15.
Nicolás, R, et al.. (1989). Relationship between the production of interferon-α/β and interferon-γ during acute toxoplasmosis. Parasitology. 99(1). 11–15. 21 indexed citations
16.
Nicolás, R, et al.. (1989). Effect of erythromycin treatment on specific immunologic response in mice.. PubMed. 37(3-4). 405–13.
17.
Egido, Jesús, et al.. (1987). The effect of the platelet-activating factor antagonist BN 52021 on the hyperglycemia indcued by alloxan. Prostaglandins. 34(2). 188–188. 1 indexed citations
18.
Egido, Jesús, et al.. (1986). Clinical Significance of Polymeric and Monomeric IgA Complexes in Patients With IgA Nephropathy. American Journal of Kidney Diseases. 8(6). 410–416. 7 indexed citations
19.
Nicolás, R, et al.. (1953). [Liver function disorders and liver function tests in peptic ulcer].. PubMed. 8(3). 136–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026